Quick Answer
ENDRA Life Sciences Inc. reported Operating Income of -$5.76 million for fiscal year 2025.
ENDRA Life Sciences Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$5.76M | +46.7% |
| 2024 | -$10.82M | -2.8% |
| 2023 | -$10.52M | +20.0% |
| 2022 | -$13.16M | -14.4% |
| 2021 | -$11.50M | +0.0% |
| 2020 | -$11.50M | -6.1% |
| 2019 | -$10.84M | -20.2% |
| 2018 | -$9.02M | -95.0% |
| 2017 | -$4.63M | -158.2% |
| 2016 | -$1.79M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.37M | +9.2% | -5.4% |
| June 30, 2025 | -$1.30M | +41.7% | +11.4% |
| March 31, 2025 | -$1.47M | +47.2% | +2.6% |
| September 30, 2024 | -$1.51M | +51.8% | +32.4% |
| June 30, 2024 | -$2.23M | +25.5% | +19.8% |
| March 31, 2024 | -$2.78M | +5.4% | +11.1% |
| September 30, 2023 | -$3.13M | +8.4% | -4.5% |
| June 30, 2023 | -$2.99M | +16.2% | -1.9% |
- ENDRA Life Sciences Inc. showed an increase of +46.7% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, ENDRA Life Sciences Inc.’s operating income has declined by 221.6% (from -$1.79 million to -$5.76 million).
- The most recent figure is from ENDRA Life Sciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: